Navitor Pharmaceuticals, Inc.

City:

Boston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-03-21

Patent Grants:

Last grant date:

2025-09-30

Top Inventors for applications by Navitor Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Navitor Pharmaceuticals, Inc.:

Eddine Saiah 3 Brookline, MA United States
Silvia Lenzini 2 Verona, Italy
George Vlasuk 2 Concord, MA United States
Sridhar Narayan 1 Belmont, MA United States

Kristina Michelle Fetalvero 1 Boston, MA United States
Steven D. TARGUM 1 Cambridge, MA United States
Steven LEVENTER 1 Boston, MA United States
Steven D. Targum 1 Boston, MA United States

David John O'Neill 1 Arlington, MA United States
Shomit Sengupta 1 Belmont, MA United States
Steven LEVENTER 1 Cambridge, MA United States

Recent patent applications by Navitor Pharmaceuticals, Inc.

Navitor Pharmaceuticals, Inc. based in Boston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-03-21 ✅ Patent 12,427,130 granted on 2025-09-30

US20240091184A1

Human necessities

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

#2 | 2024-02-08 ✅ Patent 12,465,583 granted on 2025-11-11

US20240041811A1

Human necessities

METHODS OF TREATMENT USING AN MTORC1 MODULATOR

#3 | 2024-01-18 ✅ Patent 12,252,456 granted on 2025-03-18

US20240018091A1

Chemistry; metallurgy

Polymorphic compounds and uses thereof

#4 | 2022-11-24 ✅ Patent 11,697,633 granted on 2023-07-11

US20220371985A1

Chemistry; metallurgy

Polymorphic compounds and uses thereof

#5 | 2022-10-27 ✅ Patent 12,378,263 granted on 2025-08-05

US20220340604A1

Chemistry; metallurgy

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

#6 | 2021-07-29 ✅ Patent 11,679,090 granted on 2023-06-20

US20210228523A1

Human necessities

Modulators of Sestrin-GATOR2 interaction and uses thereof

#7 | 2021-06-10 ✅ Patent 11,723,890 granted on 2023-08-15

US20210169835A1

Human necessities

Methods of treatment using an mTORC1 modulator

Also check out Navitor Pharmaceuticals, Inc.'s (Boston, United States) applicant profile with 4 patent applications submitted.

AssigneeID:

600581 ⎘